These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32924431)

  • 41. Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles.
    Dhanasooraj D; Kumar RA; Mundayoor S
    Methods Mol Biol; 2016; 1404():377-392. PubMed ID: 27076312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
    Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
    Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
    Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
    Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
    Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
    Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of target-tunable P22 VLP-based delivery nanoplatforms using bacterial superglue.
    Kim H; Choi H; Bae Y; Kang S
    Biotechnol Bioeng; 2019 Nov; 116(11):2843-2851. PubMed ID: 31329283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
    Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery.
    Lee KW; Tey BT; Ho KL; Tejo BA; Tan WS
    Mol Pharm; 2012 Sep; 9(9):2415-23. PubMed ID: 22775561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
    Mohsen MO; Zha L; Cabral-Miranda G; Bachmann MF
    Semin Immunol; 2017 Dec; 34():123-132. PubMed ID: 28887001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decoration of virus-like particles with an enzymatic activity of biomedical interest.
    Cayetano-Cruz M; Coffeen CF; Valadez-García J; Montiel C; Bustos-Jaimes I
    Virus Res; 2018 Aug; 255():1-9. PubMed ID: 29964063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new approach for therapeutic vaccination against chronic HBV infections.
    Zahn T; Akhras S; Spengler C; Murra RO; Holzhauser T; Hildt E
    Vaccine; 2020 Mar; 38(15):3105-3120. PubMed ID: 32113806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
    Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
    Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.
    Shan W; Zhang D; Wu Y; Lv X; Hu B; Zhou X; Ye S; Bi S; Ren L; Zhang X
    Nanomedicine; 2018 Apr; 14(3):725-734. PubMed ID: 29275067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GE11-antigen-loaded hepatitis B virus core antigen virus-like particles efficiently bind to TNBC tumor.
    Zhang L; Tang L; Jiang Y; Wang C; Huang L; Ding T; Zhang T; Li H; Xie L
    Front Oncol; 2023; 13():1110751. PubMed ID: 37020877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection.
    Li X; Pan C; Sun P; Peng Z; Feng E; Wu J; Wang H; Zhu L
    Nano Res; 2022; 15(2):1645-1653. PubMed ID: 34405037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
    Hong JY; Chen TH; Chen YJ; Liu CC; Jan JT; Wu SC
    Antiviral Res; 2019 Apr; 164():12-22. PubMed ID: 30738089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.
    Joshi H; Lewis K; Singharoy A; Ortoleva PJ
    Vaccine; 2013 Oct; 31(42):4841-7. PubMed ID: 23933338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
    Chan JA; Wetzel D; Reiling L; Miura K; Drew DR; Gilson PR; Anderson DA; Richards JS; Long CA; Suckow M; Jenzelewski V; Tsuboi T; Boyle MJ; Piontek M; Beeson JG
    PLoS One; 2019; 14(9):e0221733. PubMed ID: 31504038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.